SCHEMBL28043713

SCHEMBL28043713

Cc1cc(C)cc(-c2cc(NCCc3c[nH]c4ccccc34)nc(N)n2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 9/20 0.53
HTR2A P28223 9/20 0.53
DRD2 P14416 8/20 0.53
HTR7 P34969 8/20 0.53
HTR6 P50406 8/20 0.53
KMT2A Q03164 5/20 0.51
MEN1 O00255 4/20 0.51
POLB P06746 1/20 0.48
SLC2A1 P11166 1/20 0.48
RAD52 P43351 1/20 0.48
HRH4 Q9H3N8 1/20 0.48
PTGDR Q13258 1/20 0.48
MAPT P10636 2/20 0.47
ALOX12 P18054 1/20 0.47
MAPK1 P28482 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
GAA P10253 1/20 0.47
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28152048 0.87 HTR2C (0.51) HTR1AHTR2AHTR7HTR6KMT2A
SCHEMBL15756990 0.83 NUDT1 (0.53) HTR1AHTR2ADRD2HTR7HTR6
SCHEMBL30885219 0.80 HTR2A (0.55) HTR1AHTR2ADRD2HTR7HTR6
SCHEMBL27201256 0.80 HTR2A (0.55) HTR1AHTR2ADRD2HTR7HTR6
SCHEMBL28043771 0.79 HRH4 (0.62) HRH4PTGDRALDH1A1TLR8
SCHEMBL7110415 0.79 HTR1A (0.48) HTR1AHTR2ADRD2HTR7HTR6
SCHEMBL28265792 0.78 HRH4 (0.51) HTR1AHTR2ADRD2HTR7HTR6
SCHEMBL2240377 0.77 GBA1 (0.47) KMT2AMEN1POLBSLC2A1RAD52
SCHEMBL28151149 0.76 HRH4 (0.64) HRH4TLR8
SCHEMBL28152083 0.75 HRH4 (0.68) HRH4MAPTTLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105143206-B Pyrimidine -2,4- diamine derivative for treating cancer 托马斯·黑勒戴药物研究基金会 2019-01-15 CN disclosed
CN-105143206-A Pyrimidine-2,4-diamine derivatives for treatment of cancer THOMAS HELLEDAYS STIFTELSE F R MEDICINSK FORSKNING 2015-12-09 CN disclosed